Originally dba as MandalMed Inc, the firm had a business model organized around out-licensing and, to be cost effective, use of non-US faciilities to undertake clinical trials, The firm also indicated intent to form alliances with external players to undertake on their behalf late stage clinical trials, sales, and marketing of the first pharmaceutical products. Though still in receipt of SBIR funding, the firm's site is no longer operational and a single-page site indicates a new name - Bioscience Laboratories - and a shift in the firm's focus.
